- Home
- CEP vs FENC Comparison
CEP vs FENC Comparison
Compare CEP & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CEP
- FENC
- Stock Information
- Founded
- CEP 2020
- FENC 1996
- Country
- CEP United States
- FENC United States
- Employees
- CEP N/A
- FENC N/A
- Industry
- CEP
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CEP
- FENC Health Care
- Exchange
- CEP NYSE
- FENC Nasdaq
- Market Cap
- CEP 133.8M
- FENC 156.9M
- IPO Year
- CEP 2024
- FENC 2001
- Fundamental
- Price
- CEP $10.38
- FENC $6.65
- Analyst Decision
- CEP
- FENC Strong Buy
- Analyst Count
- CEP 0
- FENC 2
- Target Price
- CEP N/A
- FENC $14.00
- AVG Volume (30 Days)
- CEP 3.2K
- FENC 55.2K
- Earning Date
- CEP 01-01-0001
- FENC 03-20-2025
- Dividend Yield
- CEP N/A
- FENC N/A
- EPS Growth
- CEP N/A
- FENC N/A
- EPS
- CEP 0.06
- FENC N/A
- Revenue
- CEP N/A
- FENC $49,348,000.00
- Revenue This Year
- CEP N/A
- FENC $170.43
- Revenue Next Year
- CEP N/A
- FENC $6.70
- P/E Ratio
- CEP $187.78
- FENC N/A
- Revenue Growth
- CEP N/A
- FENC 278.09
- 52 Week Low
- CEP $9.99
- FENC $3.96
- 52 Week High
- CEP $10.95
- FENC $11.49
- Technical
- Relative Strength Index (RSI)
- CEP N/A
- FENC 58.24
- Support Level
- CEP N/A
- FENC $6.57
- Resistance Level
- CEP N/A
- FENC $6.96
- Average True Range (ATR)
- CEP 0.00
- FENC 0.26
- MACD
- CEP 0.00
- FENC -0.02
- Stochastic Oscillator
- CEP 0.00
- FENC 61.25
About CEP CANTOR EQUITY PARTNERS INC
Cantor Equity Partners Inc is a blank check company.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.